Chad Cowan's most recent trade in Century Therapeutics Inc was a trade of 265,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 265,000 | 265,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 135,000 | 1,178,476 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 02 Jan 2026 | 1,611 | 1,043,476 | - | 1.0 | 1,603 | Common Stock |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 22 Dec 2025 | 58,060 | 1,045,087 | - | 0.8 | 49,252 | Common Stock |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 20 Nov 2025 | 5,462 | 987,027 | - | 0.5 | 2,736 | Common Stock |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2025 | 762,543 | 992,489 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 230,306 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | 01 Oct 2024 | 446,250 | 446,250 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | 01 Oct 2024 | 74,376 | 210,806 | - | 0 | Common Stock |